M3 Inc
F:4YC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M3 Inc
F:4YC
|
JP |
|
M
|
More Return PCL
SET:MORE
|
TH |
|
B
|
Beiersdorf AG
XMUN:BEI
|
DE |
Intrinsic Value
The intrinsic value of 
M3 Inc (4YC) under the Base Case is 9.071 EUR per share.
Compared with the current market price of 10.495 EUR, the stock appears
Overvalued by 14% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What M3 Does
M3 Inc. is a Japan-based healthcare information company built around online services for doctors and other medical professionals. Its core business is a set of physician-focused websites and digital platforms where doctors read medical news, search reference material, exchange opinions, and access tools that help with daily clinical work. It also runs job-matching services for doctors and other healthcare workers, plus services that help pharmaceutical companies reach medical professionals.
- Headquarters
- Japan JP
- Employees
- 15 360
- IPO date
- Sep 16, 2004
M3 has no economic moat
M3 Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
M3 Inc
Earnings Waterfall
M3 Inc
The intrinsic value for M3 Inc (4YC) under the Base Case is 9.071 EUR.
Compared with the current market price of 10.495 EUR, the stock appears Overvalued by 14% .